Patrick R. Secor

Patrick R. Secor

Auto-generated profile, based on publicly available information

Patrick R. Secor

Affiliations Department of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America, Center for Biofilm Engineering, Montana State University, Bozeman, Montana, United States of America

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2019 in Science
Verified
Journal Article
Closed access
PDF file
JSJohanna M. Sweere
Johanna M. Sweere
JBJonas D Van Belleghem
Jonas D Van Belleghem
HIHeather Ishak
Heather Ishak
MBMichelle S. Bach
Michelle S. Bach
MPMedeea Popescu
Medeea Popescu
PBPaul Bollyky
Paul Bollyky
Phage subverts immune response: Pseudomonas aeruginosa ( Pa ) is a multidrug-resistant Gramnegative bacterium commonly found in health care settings. Pa infections frequently result in considerable morbidity and mortality. Sweere et al. found that a type of temperate filamentous bacteriophage that infects and integrates into Pa is associated with chronic human wound infections. Likewise, wounds in mice colonized with phage-infected Pa were more severe and longer-lasting than those colonized by Pa alone. Immune cell uptake of phage-infected Pa resulted in phage RNA production and inappropriate antiviral immune responses, impeding bacterial clearance. Both phage vaccination and transfer of antiphage antibodies were protective against Pa infection. Science , this issue p. eaat9691

1 November 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
PSPatrick R. Secor
Patrick R. Secor
JSJohanna M. Sweere
Johanna M. Sweere
LMLia A. Michaels
Lia A. Michaels
AMAndrey V. Malkovskiy
Andrey V. Malkovskiy
DLDaniel Lazzareschi
Daniel Lazzareschi
PBPaul L. Bollyky
Paul L. Bollyky

16 October 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PSPatrick R. Secor
Patrick R. Secor
LMLia A. Michaels
Lia A. Michaels
ARAnina Ratjen
Anina Ratjen
LJLaura K. Jennings
Laura K. Jennings
PSPradeep K. Singh
Pradeep K. Singh
Significance: Bacteria live in aggregates at sites of chronic infection, and aggregated growth is thought to be important in producing key infection phenotypes such as antibiotic tolerance. We found that entropic forces generated by polymers abundant at chronic infection sites can cause bacteria to aggregate by a mechanism known as “depletion aggregation.” This aggregation mechanism does not require biofilm formation functions, but it does cause bacteria to become much less susceptible to killing by antibiotics. These findings indicate that aggregation could be a default growth mode at infection sites. It might be useful to target mechanisms of depletion-mediated antibiotic tolerance for the treatment of chronic infections.

1 February 2021 in Cell Reports
Verified
Journal Article
Open access
LJLaura K. Jennings
Laura K. Jennings
JDJulia E. Dreifus
Julia E. Dreifus
CRCourtney Reichhardt
Courtney Reichhardt
KSKelly M. Storek
Kelly M. Storek
PSPatrick R. Secor
Patrick R. Secor
MPMatthew R. Parsek
Matthew R. Parsek
In cystic fibrosis (CF) airways, Pseudomonas aeruginosa forms cellular aggregates called biofilms that are thought to contribute to chronic infection. To form aggregates, P. aeruginosa can use different mechanisms, each with its own pathogenic implications. However, how they form in vivo is controversial and unclear. One mechanism involves a bacterially produced extracellular matrix that holds the aggregates together. Pel and Psl exopolysaccharides are structural and protective components of this matrix. We develop an immunohistochemical method to visualize Pel and Psl in CF sputum. We demonstrate that both exopolysaccharides are expressed in the CF airways and that the morphology of aggregates is consistent with an exopolysaccharide-dependent aggregation mechanism. We reason that the cationic exopolysaccharide Pel may interact with some of the abundant anionic host polymers in sputum. We show that Pel binds extracellular DNA (eDNA) and that this interaction likely impacts current therapies by increasing antimicrobial tolerance and protecting eDNA from digestion.

21 February 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
PSPatrick R. Secor
Patrick R. Secor
EBElizabeth B. Burgener
Elizabeth B. Burgener
MKM. Kinnersley
M. Kinnersley
LJLaura K. Jennings
Laura K. Jennings
VRValery Roman-Cruz
Valery Roman-Cruz
PBPaul Bollyky
Paul Bollyky
Pf bacteriophage are temperate phages that infect the bacterium Pseudomonas aeruginosa, a major cause of chronic lung infections in cystic fibrosis (CF) and other settings. Pf and other temperate phages have evolved complex, mutualistic relationships with their bacterial hosts that impact both bacterial phenotypes and chronic infection. We and others have reported that Pf phages are a virulence factor that promote the pathogenesis of P. aeruginosa infections in animal models and are associated with worse skin and lung infections in humans. Here we review the biology of Pf phage and what is known about its contributions to pathogenesis and clinical disease. First, we review the structure, genetics, and epidemiology of Pf phage. Next, we address the diverse and surprising ways that Pf phages contribute to P. aeruginosa phenotypes including effects on biofilm formation, antibiotic resistance, and motility. Then, we cover data indicating that Pf phages suppress mammalian immunity at sites of bacterial infection. Finally, we discuss recent literature implicating Pf in chronic P. aeruginosa infections in CF and other settings. Together, these reports suggest that Pf bacteriophage have direct effects on P. aeruginosa infections and that temperate phages are an exciting frontier in microbiology, immunology, and human health.

17 April 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
EBElizabeth Burgener
Elizabeth Burgener
JSJohanna M. Sweere
Johanna M. Sweere
MBMichelle S. Bach
Michelle S. Bach
PSPatrick R. Secor
Patrick R. Secor
NHNaomi Haddock
Naomi Haddock
CMCarlos E. Milla
Carlos E. Milla
Pseudomonas strains that produce filamentous bacteriophage are associated with chronic infection and increased antibiotic resistance in patients with cystic fibrosis.